Saniona AB (publ) Namn-Aktier o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

52.74%

Market Cap

-

P/E Ratio

9.61

Dividend Yield

0.00 %

Earnings per Share

0.20 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.148 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:57:13 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW1.1711.141
PREV. DAY'S PRICE1.141 (07/20)
CHANGE DAY BEFORE
+0.01
0.61 %
52 WEEK HIGH / LOW2.655 (01/29)0.699 (08/20)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.110.160.20--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-4.529.61--
PRICE - BOOK RATIO
-3.904.61--
PRICE - SALES RATIO
15.022.576.46--
PRICE - CASH FLOW RATIO
-3.4610.25--
Further Key Figures

Master Data

WKN
A110VV
ISIN
SE0005794617
SYMBOL
30S
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
SANIONA AB (PUBL)
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.04 %
1.51 %
-17.08 %
-43.37 %
52.74 %
50.53 %
-23.11 %
-40.51 %
HIGH1.211.231.462.662.662.662.662.66
LOW1.141.121.121.120.700.140.141.12

Dividende

pro Aktie
SANIONA AB (PUBL) does not deliver dividend information

Company profile

Saniona AB is a clinical-stage biopharmaceutical company, which engages in the research and development on drugs for diseases of the central nervous system, autoimmune diseases, and metabolic diseases. Its research focuses on ion channels, which are made up of protein that enables and controls the passage of charged ions across cell membranes. Its product pipeline includes Tesofensine, Tesomet, SAN2219, SAN2465, and SAN903. The company was founded by Claus Tycho Bræstrup, Anker Gunvald Lundemose, Jørgen Drejer, Palle Christophersen, Thomas Feldthus, and Janus Schreiber Larsen in 2011 and is headquartered Glostrup, Denmark.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.